查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1715451

微生物检测市场（按产品、技术、生物体类型和应用）—2025-2030 年全球预测

Microbial Testing Market by Product, Technology, Organism Type, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

微生物检测市场预计到 2024 年将达到 42.9 亿美元，到 2025 年将达到 49.1 亿美元，到 2030 年将达到 99 亿美元，复合年增长率为 14.93%。

主要市场统计数据
基准年2024年 42.9亿美元
预计2025年 49.1亿美元
预测年份 2030 99亿美元
复合年增长率（%） 14.93%

微生物检测已成为无数产业确保产品安全、品质和功效的重要工具。随着对可靠、快速和准确的诊断解决方案的需求不断增加，微生物学检测领域在科学创新和严格的监管要求的推动下正在稳步发展。本报告概述了现代微生物学测试的方面，并深入探讨了重塑传统方法的进步、新机会以及日益复杂的市场中相关人员面临的挑战。科技创新的快速发展，加上人们对公共卫生和环境安全的认识不断提高，正在重新定义医疗保健、製药、食品加工和环境监测等领域的微生物检测和分析方式。

微生物学测试的重要性怎么强调也不为过。在公共和法规遵从与商业性需求相交织的时代，建立强而有力的测试通讯协定至关重要。当今的情况取决于精度和速度之间的微妙平衡，这使得公司能够快速检测有害污染物和病原体，同时保持高吞吐量。不断演变的微生物威胁和对更多样化测试方法的需求迫使各行各业投资于先进的方法和创新工具，将微生物学测试转变为现代品质保证框架的重要组成部分。

此外，生物学和技术的融合培育了一个开创性的环境，其中数位解决方案和自动化越来越多地融入传统的测试机制中。这种演变不仅提高了效率和准确性，而且还促进了可扩展的测试程序，以满足全球化市场的需求。当组织应对这些动态变化时，了解微生物学测试的多方面方面对于跟上行业进步并确保在面临新挑战时的韧性至关重要。

改变微生物检测市场

近年来，微生物学检测领域经历了一系列变革，重新定义了相关人员多年来使用的通讯协定和实践。特别是引入整合资料分析和快速处理系统的最尖端科技，简化了测试程序并大大缩短了交付时间。从传统的基于培养的方法向 PCR 和光谱法等更复杂的技术的转变证明了市场对更高精度和高效率需求的敏捷反应。

自动化和机器人技术的进步也为实验室在不影响品质的情况下处理大量测试铺平了道路。这在需要快速决策的情况下尤其重要，例如临床诊断、食品安全和疫情调查。随着国际法规日益严格，品质标准日益严格，许多组织正在采用这些创新解决方案来保持竞争力并确保合规性。此外，尖端生物感测器和微阵列技术的整合有助于提高早期侦测能力，使产业不仅能够诊断现有问题，还能预测潜在威胁。

永续实践的需求进一步推动了微生物学测试领域的演变。随着人们对环境安全和资源保护的日益关注，实验室操作中的环保协议和高效的废弃物管理也成为关注的重点。产业参与者正在透过重新调整业务策略、投资研发以及利用与技术提供者的伙伴关係关係来不断适应这些变化。这种积极主动的方法对于维持长期成长和确保从临床到製造等广泛环境中的安全至关重要。

总的来说，这些变革趋势凸显了一个正处于快速变化中的行业——一个决心突破科学能力界限以应对现代挑战的行业。先进技术、自动化和永续实践的整合将代表新常态，为那些能够驾驭这个不断变化的环境的人提供竞争优势。

主要微生物检测领域分析

微生物学检测市场进行详细分析，可以发现其市场结构丰富，可依产品类型、技术、生物类型和应用等因素进行细分。在考虑产品细分时，市场透过两大类别进行仔细审查：仪器和试剂以及消耗品。该仪器的特点是诊断设备先进，处于技术进步的前沿。同时，试剂和耗材透过高品质的化学品和即用型溶液确保测试过程的准确性。

从技术角度来看，微生物检测领域包括许多现代技术，例如生物感测器、层析法、基于培养的方法、免疫学技术、微阵列技术、PCR技术和光谱法。其中，免疫学技术又分为ELISA套件和横向流动化验，体现了人们对更有效率、更快速的诊断方法的持续追求。这些方法的进步使得高度敏感和特异性的检测能力能够解决病原体检测的新复杂性。

基于生物体类型的市场区隔提供了对各种微生物（包括细菌、真菌、寄生虫和病毒）的市场动态的细緻了解。每个类别都面临不同的挑战，需要客製化的检测策略，这会影响不同环境中的测试方法和技术选择。另一方面，基于应用的细分将分析扩展到各个工业垂直领域，如化学和材料製造、临床诊断、环境监测、食品检测、製药製造等。在临床领域，涵盖血液感染疾病、胃肠道疾病、牙周疾病、呼吸系统疾病、性行为感染传染病和尿道感染的评估提供了深刻的见解，并强调了技术与患者照护之间的复杂相互作用。同样，环境应用进一步按土壤污染评估和水质测试等参数细分，而食品测试部分涵盖食品和饮料、乳製品、水果和蔬菜、家禽和肉类以及鱼贝类。每个类别都需要严格的测试通讯协定，不仅要确保安全，还要符合各个市场的严格监管标准。

这种全面的細項分析提供了有关市场分類的宝贵见解，使相关人员能够根据其特定要求和技术创新来客製化策略。认识到这些不同的部分将突出最迫切需要投资的领域，并最终推动更有针对性的诊断解决方案的研究和开发。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 生物技术和生命科学的显着增长推动了微生物检测行业的发展
      • 食品工业的发展需要进行微生物检测以确保食品安全
      • 都市化和工业化的不断推进推动了微生物检测的需求。
    • 限制因素
      • 测试结果的准确性和主观解释问题
    • 机会
      • 与学术和研究机构的合作将促进微生物学测试的发展。
      • 增加人工智慧和机器学习的应用，以提高实验室的准确性和速度
    • 任务
      • 实验室缺乏标准化通讯协定导致测试结果不一致
  • 市场区隔分析
    • 产品：可用于样品製备、微生物生长和鑑定过程的试剂和消耗品。
    • 应用：微生物食品检测在病原体检测和安全标准的进展
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

第六章微生物检测市场（依产品）

  • 装置
  • 试剂和耗材

第七章 微生物检测市场（依技术）

  • 生物感测器
  • 层析法
  • 基于文化的方法
  • 免疫学技术
    • ELISA套件
    • 横向流动化验
  • 微阵列技术
  • PCR技术
  • 光谱分析

8. 微生物检测市场（依生物体类型）

  • 细菌
  • 真菌
  • 寄生虫
  • 病毒

第九章微生物检测市场（依应用）

  • 化学和材料製造
  • 临床
    • 血流感染疾病
    • 消化系统疾病
    • 牙周病
    • 呼吸系统疾病
    • 性行为感染传染病
    • 尿道感染
  • 环境
    • 土壤污染评估
    • 水质检测
  • 食品检验
    • 喝
    • 乳製品
    • 水果和蔬菜
    • 鸡肉和肉类
    • 海鲜
  • 製药

10.美洲微生物检测市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第 11 章：亚太微生物检测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第 12 章欧洲、中东和非洲微生物学检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • 3M Company
  • Abbott Laboratories
  • Accepta Ltd.
  • AEMTEK Laboratories
  • Agilent Technologies, Inc.
  • ALS Limited
  • ARL Bio Pharma, Inc.
  • Beckman Coulter Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • bioMerieux SA
  • Biosan Laboratories, Inc.
  • Bruker Corporation
  • Charles River Laboratories
  • Dohler GmbH
  • Ecolyse, Inc.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd.
  • Intertek Group PLC
  • LuminUltra Technologies Ltd.
  • Medicinal Genomics Corp.
  • Merck KGaA
  • Microbac Laboratories Inc.
  • Nelson Laboratories, LLC
  • NEOGEN Corporation
  • QIAGEN NV
  • Sartorius AG
  • SGS SA
  • Shimazdu Corporation
  • Thermo Fisher Scientific Inc.
  • TUV SUD
Product Code: MRR-036C5CF3A80C

The Microbial Testing Market was valued at USD 4.29 billion in 2024 and is projected to grow to USD 4.91 billion in 2025, with a CAGR of 14.93%, reaching USD 9.90 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 4.29 billion
Estimated Year [2025] USD 4.91 billion
Forecast Year [2030] USD 9.90 billion
CAGR (%) 14.93%

Microbial testing has emerged as a critical tool in ensuring the safety, quality, and efficacy of products across a myriad of industries. With the rising demand for reliable, rapid, and accurate diagnostic solutions, the field of microbial testing is undergoing steady evolution, driven by scientific innovation and stringent regulatory mandates. This report outlines the foundational aspects of modern microbial testing, offering an in-depth look at advancements that have reshaped traditional practices, emerging opportunities, and the challenges that stakeholders face in an increasingly complex market. The rapid pace of technological innovation, combined with heightened awareness regarding public health and environmental safety, has redefined how sectors such as healthcare, pharmaceuticals, food processing, and environmental monitoring approach microbial detection and analysis.

The significance of microbial testing cannot be overstated. In an era where public safety and regulatory compliance intersect with commercial imperatives, establishing robust testing protocols is paramount. Today's landscape is defined by a finer balance between precision and speed, enabling organizations to detect harmful contaminants and pathogens swiftly while maintaining high throughput. The evolving nature of microbial threats and the demand for diversification in testing approaches have compelled industry players to invest in advanced methodologies and innovative tools, thus transforming microbial testing into an indispensable component of modern quality assurance frameworks.

Furthermore, the convergence of biology and technology has fostered a groundbreaking environment where digital solutions and automation are increasingly integrated into traditional testing mechanisms. This evolution not only amplifies efficiency and accuracy but also facilitates scalable testing procedures that can meet the demands of a globalized market. As organizations continue to navigate through these dynamic shifts, understanding the multi-faceted aspects of microbial testing will be essential in keeping pace with industry advances and ensuring resilience in the face of emerging challenges.

Transformative Shifts in the Microbial Testing Landscape

In recent years, the microbial testing landscape has experienced a series of transformative shifts that have redefined the protocols and practices historically used by stakeholders. The infusion of cutting-edge technologies, particularly those that integrate data analytics with rapid processing systems, has streamlined testing procedures, reducing turnaround times significantly. The shift from traditional culture-based methodologies to more sophisticated techniques such as PCR and spectrometry is a testament to the market's agile response to the demands for greater accuracy and efficiency.

Advancements in automation and robotics have also paved the way for labs to handle higher volumes of tests without compromising quality. This is critical, especially in situations where rapid decision-making is essential-such as in clinical diagnostics, food safety, or outbreak investigations. As global regulations tighten and quality standards become more rigorous, many organizations have embraced these innovative solutions to maintain competitiveness and ensure compliance. Moreover, the integration of state-of-the-art biosensors and microarray technologies contributes to early detection capabilities, enabling industries to not only diagnose existing problems but also predict potential threats.

This evolution within the microbial testing domain is further accelerated by the need for sustainable practices. With an increased focus on environmental safety and resource conservation, eco-friendly protocols coupled with efficient waste management in laboratory operations have also become significant focal points. Industry players are continually adapting to these changes by re-aligning their operational strategies, investing in research and development, and leveraging collaborative partnerships with technology providers. This proactive approach is essential for sustaining long-term growth and ensuring the safety of environments ranging from clinical to manufacturing settings.

Overall, these transformative trends underscore an industry in the midst of rapid change-one that is determined to push the boundaries of scientific capability in order to meet modern-day challenges. The integration of advanced technologies, automation, and sustainable practices marks the new normal, providing a competitive edge to those who can adeptly navigate this ever-changing landscape.

Key Segmentation Insights in Microbial Testing

A granular analysis of the microbial testing market reveals a rich tapestry of segmentation driven by factors such as product type, technology, organism type, and application. When considering product segmentation, the market is meticulously studied through two primary categories - instruments and reagents along with consumables. Instruments, characterized by sophisticated diagnostic equipment, stand at the forefront of technological advancement, while reagents and consumables ensure that the testing process maintains its precision through high-quality chemicals and ready-to-use solutions.

From a technological standpoint, the field of microbial testing encompasses an array of modern techniques including biosensors, chromatography, culture-based methods, immunological techniques, microarray technology, PCR technology, and spectrometry. Among these, immunological techniques are further dissected into ELISA kits and lateral flow assays, which reflect the constant push towards more efficient and rapid diagnostic procedures. The evolution of these methodologies enables testing capacities to be both highly sensitive and specific, meeting the emerging complexities of pathogen detection.

The segmentation based on organism type provides a nuanced understanding of the market dynamics across different microbial entities such as bacteria, fungi, parasites, and viruses. Each category represents distinct challenges and requires tailored detection strategies, influencing the choice of testing methods and technologies in diverse settings. Meanwhile, segmentation based on application extends this analysis into various industrial sectors including chemical and material manufacturing, clinical diagnostics, environmental monitoring, food testing, and pharmaceutical production. In the clinical realm, deeper insights are derived from assessments targeting bloodstream infections, gastrointestinal diseases, periodontal conditions, respiratory illnesses, sexually transmitted diseases, and urinary tract infections, highlighting the intricate interplay between technology and patient care. Similarly, environmental applications are further delineated by parameters such as soil contamination assessment and water quality testing, while food testing segments extend to beverages, dairy products, fruits and vegetables, poultry and meat, and seafood. Each of these categories demands rigorous testing protocols that not only ensure safety but also adhere to stringent regulatory standards across diverse markets.

This comprehensive segmentation analysis offers valuable insights into how the market is partitioned and allows stakeholders to align their strategies in accordance with specific requirements and technological innovations. Recognizing these diverse segments provides clarity on where investments are most urgently needed, ultimately driving more focused research and development efforts in tailored diagnostic solutions.

Based on Product, market is studied across Instruments and Reagents & Consumables.

Based on Technology, market is studied across Biosensors, Chromatography, Culture-Based Methods, Immunological Techniques, Microarray Technology, PCR Technology, and Spectrometry. The Immunological Techniques is further studied across ELISA Kits and Lateral Flow Assays.

Based on Organism Type, market is studied across Bacteria, Fungi, Parasites, and Viruses.

Based on Application, market is studied across Chemical & Material Manufacturing, Clinical, Environment, Food Testing, and Pharmaceutical. The Clinical is further studied across Bloodstream Infections, Gastrointestinal Diseases, Periodontal Diseases, Respiratory Diseases, Sexually Transmitted Diseases, and Urinary Tract Infections. The Environment is further studied across Soil Contamination Assessment and Water Quality Testing. The Food Testing is further studied across Beverages, Dairy Products, Fruits & Vegetables, Poultry & Meat, and Seafood.

Global Penetration and Regional Insights in Microbial Testing

The global reach of microbial testing mirrors the diverse demands and regulatory landscapes encountered in different regions. In the Americas, a strong emphasis on regulatory compliance and advanced diagnostic infrastructure drives market growth. This region benefits from a well-established healthcare ecosystem and a mature industrial base, where rapid diagnostic capabilities are integral to both public health and commercial productivity.

Across Europe, the Middle East, and Africa, evolving regulatory environments coupled with increasing awareness about environmental safety and food quality are fostering significant adoption of advanced microbial testing solutions. Here, the necessity to implement robust testing protocols is underscored by stringent standards imposed by governmental agencies and international bodies. The region benefits from collaborative initiatives across various sectors, leading to the integration of innovative technologies that mitigate regional challenges while promoting higher standards of operational excellence.

In the Asia-Pacific region, rapid industrialization, rising healthcare expenditures, and increased consumer awareness are the primary drivers behind the burgeoning demand for microbial testing. As economies continue to expand with a burgeoning middle class, there is an intensified focus on ensuring the safety of consumables and pharmaceuticals, as well as on maintaining quality standards in the rapidly growing food and manufacturing sectors. The region's dynamic landscape encourages the adoption of state-of-the-art testing methodologies, helping local industries synchronize with global best practices and adhere to international quality specifications.

These regional insights underscore the importance of adopting localized strategies that consider not only technological prowess but also the unique regulatory and cultural factors inherent to each market. By appreciating these nuances, industry players can tailor their approaches to maximize market penetration and drive sustainable growth across different geographies.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Driving Innovation and Market Leadership

Several industry stalwarts have been instrumental in propelling the microbial testing market forward by investing heavily in research and development, streamlining operational efficiencies, and expanding their global footprint. Prominent players such as 3M Company and Abbott Laboratories have consistently showcased innovation by integrating advanced diagnostic technologies with user-friendly platforms, ensuring both reliability and scalability in testing procedures.

Companies including Accepta Ltd. and AEMTEK Laboratories have carved out significant niches by tailoring their products to meet the exacting standards of both industrial and clinical environments. Agilent Technologies, Inc. and ALS Limited have distinguished themselves through a commitment to precision, offering comprehensive solutions that cover the entire spectrum of microbial analysis. ARL Bio Pharma, Inc. and Beckman Coulter Inc. are recognized for their contributions to advancing automated detection methods while consistently ensuring that quality is never compromised.

Key market leaders such as Becton, Dickinson and Company along with Bio-Rad Laboratories Inc. have solidified their market positions by continuously pushing the envelope in innovation and operational excellence. Other companies like bioMerieux SA, Biosan Laboratories, Inc., and Bruker Corporation have enhanced their competitive advantage by merging technological innovations with strategic regional expansions. Organizations like Charles River Laboratories and Dohler GmbH have successfully blended traditional and modern methodologies to offer robust, end-to-end testing solutions catered to diverse industry needs.

The competitive landscape is further enriched by players such as Ecolyse, Inc., Eurofins Scientific SE, and F. Hoffmann-La Roche Ltd., who have maintained leadership through their persistent focus on quality and innovation. Intertek Group PLC, LuminUltra Technologies Ltd., and Medicinal Genomics Corp. have also contributed significantly by not only adopting state-of-the-art technologies but also by embracing comprehensive quality management systems. Merck KGaA and Microbac Laboratories Inc. have been recognized for their commitment to ensuring testing accuracy, thereby reinforcing customer trust across the globe. Additional contributions from Nelson Laboratories, LLC, NEOGEN Corporation, QIAGEN N.V., Sartorius AG, SGS S.A., Shimazdu Corporation, Thermo Fisher Scientific Inc., and TUV SUD collectively illustrate a market that values interoperability, technological integration, and strategic foresight as key drivers for sustained growth.

Through their relentless pursuit of excellence, these companies have woven a narrative of innovation, resilience, and market leadership. Their endeavors not only underscore the transformative potential of microbial testing but also set the stage for future advancements that promise to redefine industry benchmarks on a global scale.

The report delves into recent significant developments in the Microbial Testing Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Accepta Ltd., AEMTEK Laboratories, Agilent Technologies, Inc., ALS Limited, ARL Bio Pharma, Inc., Beckman Coulter Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., bioMerieux SA, Biosan Laboratories, Inc., Bruker Corporation, Charles River Laboratories, Dohler GmbH, Ecolyse, Inc., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Intertek Group PLC, LuminUltra Technologies Ltd., Medicinal Genomics Corp., Merck KGaA, Microbac Laboratories Inc., Nelson Laboratories, LLC, NEOGEN Corporation, QIAGEN N.V., Sartorius AG, SGS S.A., Shimazdu Corporation, Thermo Fisher Scientific Inc., and TUV SUD. Actionable Recommendations for Industry Leaders in Microbial Testing

For decision-makers aiming to harness the full potential of the microbial testing market, several strategic imperatives must be considered. First, it is essential to invest in advanced automation and digital technologies that can improve efficiency, reduce manual errors, and enable rapid data processing. Embracing tools like PCR and spectrometry in conjunction with traditional methods will enable faster turnaround times and more precise diagnostics. Second, it is advisable to tailor product development efforts towards addressing niche market segments. By focusing on specialized areas within the clinical, environmental, and food testing domains, companies can develop bespoke solutions that resonate with targeted consumer requirements and regulatory frameworks.

Collaboration across interdisciplinary teams that include experts in biology, engineering, and data science is another critical recommendation. Such collaborative efforts can lead to the creation of integrated platforms that merge diagnostic accuracy with real-time data analytics. This is particularly important in scenarios where timely intervention is crucial, such as in outbreak management or in environments with stringent safety standards. Furthermore, working closely with regulatory bodies and standardization organizations can help in preemptively addressing compliance challenges and in paving the way for smoother market entry.

Investments in research and development should be prioritized to continuously explore emerging technologies and improve the sensitivity and specificity of testing methods. Industry leaders are encouraged to develop strategic partnerships with academic institutions and technology firms to stay ahead of the curve on innovation trends. Additionally, adopting a customer-centric approach that involves collecting and analyzing feedback from end-users can provide valuable insights into product performance and areas for improvement.

It is also imperative to diversify geographical outreach by tailoring strategies to resonate with regional requirements. Companies should leverage localized market research to understand regional dynamics and to identify unique opportunities for growth in areas such as the Americas, Europe, Middle East and Africa, and Asia-Pacific. By aligning product portfolios with regional demands and regulatory standards, companies can ensure sustained market penetration and long-term competitiveness.

Finally, industry leaders should not underestimate the importance of robust quality control and risk management strategies. Implementing comprehensive quality management systems and regularly updating testing protocols can help in mitigating potential risks, ensuring that the highest standards are consistently met. A proactive stance on quality assurance not only builds trust with stakeholders but also reinforces the brand's reputation in the marketplace.

Conclusion: Charting the Future of Microbial Testing

The landscape of microbial testing has been irrevocably transformed by scientific innovation, evolving market requirements, and the relentless pursuit of excellence. This transformative journey has led to the integration of advanced diagnostic technologies, the refinement of testing protocols across various segments, and the adaptation of global strategies that address both regulatory and market-specific challenges. With a keen focus on automation, data integration, and specialized testing solutions, the industry stands poised to address emerging microbial threats in a landscape that is increasingly competitive and dynamic.

A comprehensive understanding of market segmentation, regional dynamics, and the competitive forces at play serves as a roadmap for stakeholders aiming to secure a competitive edge. The interplay of instruments, consumables, advanced technological applications, and diverse testing methods has laid the foundation for a future where precision, efficiency, and rapid response are paramount. This is further enriched by the evolving roles of key players who continuously drive innovation, ensuring that quality and safety are maintained even in the face of unprecedented challenges.

Looking ahead, the path forward is illuminated by opportunities for growth, collaboration, and strategic agility. By harnessing the insights derived from comprehensive market analysis, industry leaders can make informed decisions that not only meet current demands but also anticipate future trends. The continuous evolution of microbial testing is a testament to the industry's commitment to safeguarding public health, ensuring environmental sustainability, and advancing scientific innovation. As these trends converge, companies that invest in technology, innovation, and strategic global outreach will undoubtedly lead the way in transforming microbial testing into a cornerstone of modern diagnostic science.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Significant growth in biotechnology and life sciences propels the microbial testing industry
      • 5.1.1.2. Growth of the food industry necessitating microbial testing to ensure food safety
      • 5.1.1.3. Rising urbanization and industrialization contributing to the escalating demand for microbial testing
    • 5.1.2. Restraints
      • 5.1.2.1. Issues related to accuracy and subjective interpretation of test results
    • 5.1.3. Opportunities
      • 5.1.3.1. Collaboration with academic institutions and research agencies fosters advancement in microbial testing
      • 5.1.3.2. Increasing applications of AI and machine learning in enhancing microbial testing accuracy and speed in laboratories
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of standardized protocols across laboratories causing inconsistencies in testing outcomes
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Utilization of reagents & consumables for sample preparation, microbial growth, and identification processes.
    • 5.2.2. Application: Advancements in microbial food testing for detecting pathogens and safety standards
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Microbial Testing Market, by Product

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Reagents & Consumables

7. Microbial Testing Market, by Technology

  • 7.1. Introduction
  • 7.2. Biosensors
  • 7.3. Chromatography
  • 7.4. Culture-Based Methods
  • 7.5. Immunological Techniques
    • 7.5.1. ELISA Kits
    • 7.5.2. Lateral Flow Assays
  • 7.6. Microarray Technology
  • 7.7. PCR Technology
  • 7.8. Spectrometry

8. Microbial Testing Market, by Organism Type

  • 8.1. Introduction
  • 8.2. Bacteria
  • 8.3. Fungi
  • 8.4. Parasites
  • 8.5. Viruses

9. Microbial Testing Market, by Application

  • 9.1. Introduction
  • 9.2. Chemical & Material Manufacturing
  • 9.3. Clinical
    • 9.3.1. Bloodstream Infections
    • 9.3.2. Gastrointestinal Diseases
    • 9.3.3. Periodontal Diseases
    • 9.3.4. Respiratory Diseases
    • 9.3.5. Sexually Transmitted Diseases
    • 9.3.6. Urinary Tract Infections
  • 9.4. Environment
    • 9.4.1. Soil Contamination Assessment
    • 9.4.2. Water Quality Testing
  • 9.5. Food Testing
    • 9.5.1. Beverages
    • 9.5.2. Dairy Products
    • 9.5.3. Fruits & Vegetables
    • 9.5.4. Poultry & Meat
    • 9.5.5. Seafood
  • 9.6. Pharmaceutical

10. Americas Microbial Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Microbial Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Microbial Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. FPNV Positioning Matrix, 2024
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. USP enhances microbiology portfolio through acquisition of Stratix Labs
    • 13.3.2. HaystackAnalytics launches comprehensive test for bacterial, fungal, and viral infections
    • 13.3.3. bioMerieux and FDA collaborate to enhance microbial detection for food safety
    • 13.3.4. Bruker Introduced New Mycobacteria and Fungi IVD Solutions for MALDI Biotyper, and a Novel LiquidArray Gastrointestinal Syndromic Panel
    • 13.3.5. Nelson Labs receives ASCA accreditation from FDA
    • 13.3.6. SGS's New Agri-Commodity and Food Testing Laboratory in Brazil Received ISO 17025 and AOAC International Accreditation
    • 13.3.7. MicroVal Approved Bio-Rad PCR Kit for Detection of STEC in Flour and Raw Dough
    • 13.3.8. Nemera and Nelson Labs Europe strengthened partnership to offer integrated services to customer
    • 13.3.9. Hardy Diagnostics Launched New Ready-To-Use Dehydrated Culture Plate
    • 13.3.10. Beckman Coulter and MeMed to Expanded Access to Proven Host Immune Response Diagnostic Able to Distinguish Between Bacterial and Viral Infections
    • 13.3.11. AstraZeneca Partnered with LBT to automate pharma microbial QC
    • 13.3.12. FASTinov collaborated with Beckman Coulter Life Sciences to bring ultra-rapid 2h-AST disruptive technology to clinical microbiology laboratories
    • 13.3.13. Thermo Fisher Scientific Inc. - Thermo Fisher Scientific Completed Acquisition of The Binding Site Group
    • 13.3.14. Roche received US FDA Emergency Use Authorization for its high-throughput automated test to detect monkeypox virus
    • 13.3.15. Charles River launched Endosafe Nexus 200
    • 13.3.16. MilliporeSigma Invested USD 286 Million in U.S. Drug Safety Testing Capacity
    • 13.3.17. Acquisition Expanded Water Microbiology Testing Capabilities Labmate Online
    • 13.3.18. ADM opened N. America microbiology lab
    • 13.3.19. SGS Acquired Industry Lab in Romania
    • 13.3.20. LuminUltra launched latest molecular diagnostic innovation with the GeneCount Corrosion Collection
    • 13.3.21. Thermo Fisher introduced new gastrointestinal bacteria detection panel
    • 13.3.22. NAMSA Acquires UK-Based Perfectus Biomed Group to Enhance Customized Microbiological Solutions
    • 13.3.23. Solvay opened a new microbiology lab for the energy sector in the UK
    • 13.3.24. Medical Genomics and UgenTec partnered to automate cannabis testing results, minimizing labor and inconsistencies
    • 13.3.25. Microgenetics developed rapid microbial test method with six-hour result time
    • 13.3.26. BD, Accelerate Diagnostics Announced Global Commercial Collaboration
    • 13.3.27. Bio-Rad buys Curiosity Diagnostics for up to USD 170 million
    • 13.3.28. bioMerieux Collaborated with FSSAI to Celebrate World Food Safety Day 2022
    • 13.3.29. PerkinElmer Expands Food Safety Testing Portfolio with AOAC Certified Microbial Count Plates
    • 13.3.30. MSU researcher received USD 769K grant to develop rapid test for foodborne pathogens - Department of Biosystems & Agricultural Engineering
    • 13.3.31. Biolog Announced New Leadership Team and Secures Major Investment to Drive Widespread Adoption of Industry-Leading Microbial Identification and Phenotypic Profiling Products
    • 13.3.32. EUR 22 million EU (USD 23.21) backing for Israeli microbiology diagnostic leader Pocared
    • 13.3.33. MilliporeSigma Launched Culture Media System For Microbiological Food Testing
    • 13.3.34. BioMerieux Acquired Antibiotic Susceptibility Test Firm Specific Diagnostics
    • 13.3.35. Thermo Fisher Scientific launched rapid environmental PCR testing solution that detects in-air SARS-CoV-2 pathogens
    • 13.3.36. BD Introduced Smart Connected Robotics to Automate Microbial Identification
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Abbott Laboratories
  • 3. Accepta Ltd.
  • 4. AEMTEK Laboratories
  • 5. Agilent Technologies, Inc.
  • 6. ALS Limited
  • 7. ARL Bio Pharma, Inc.
  • 8. Beckman Coulter Inc.
  • 9. Becton, Dickinson and Company
  • 10. Bio-Rad Laboratories Inc.
  • 11. bioMerieux SA
  • 12. Biosan Laboratories, Inc.
  • 13. Bruker Corporation
  • 14. Charles River Laboratories
  • 15. Dohler GmbH
  • 16. Ecolyse, Inc.
  • 17. Eurofins Scientific SE
  • 18. F. Hoffmann-La Roche Ltd.
  • 19. Intertek Group PLC
  • 20. LuminUltra Technologies Ltd.
  • 21. Medicinal Genomics Corp.
  • 22. Merck KGaA
  • 23. Microbac Laboratories Inc.
  • 24. Nelson Laboratories, LLC
  • 25. NEOGEN Corporation
  • 26. QIAGEN N.V.
  • 27. Sartorius AG
  • 28. SGS S.A.
  • 29. Shimazdu Corporation
  • 30. Thermo Fisher Scientific Inc.
  • 31. TUV SUD

LIST OF FIGURES

  • FIGURE 1. MICROBIAL TESTING MARKET MULTI-CURRENCY
  • FIGURE 2. MICROBIAL TESTING MARKET MULTI-LANGUAGE
  • FIGURE 3. MICROBIAL TESTING MARKET RESEARCH PROCESS
  • FIGURE 4. MICROBIAL TESTING MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL MICROBIAL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL MICROBIAL TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL MICROBIAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MICROBIAL TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL MICROBIAL TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL MICROBIAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL MICROBIAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS MICROBIAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 17. AMERICAS MICROBIAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES MICROBIAL TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 19. UNITED STATES MICROBIAL TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC MICROBIAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC MICROBIAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA MICROBIAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA MICROBIAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. MICROBIAL TESTING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 25. MICROBIAL TESTING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. MICROBIAL TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL MICROBIAL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MICROBIAL TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MICROBIAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MICROBIAL TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MICROBIAL TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MICROBIAL TESTING MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MICROBIAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MICROBIAL TESTING MARKET SIZE, BY BIOSENSORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MICROBIAL TESTING MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MICROBIAL TESTING MARKET SIZE, BY CULTURE-BASED METHODS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MICROBIAL TESTING MARKET SIZE, BY IMMUNOLOGICAL TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MICROBIAL TESTING MARKET SIZE, BY ELISA KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MICROBIAL TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MICROBIAL TESTING MARKET SIZE, BY IMMUNOLOGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MICROBIAL TESTING MARKET SIZE, BY MICROARRAY TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL MICROBIAL TESTING MARKET SIZE, BY PCR TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL MICROBIAL TESTING MARKET SIZE, BY SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL MICROBIAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL MICROBIAL TESTING MARKET SIZE, BY BACTERIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL MICROBIAL TESTING MARKET SIZE, BY FUNGI, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL MICROBIAL TESTING MARKET SIZE, BY PARASITES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL MICROBIAL TESTING MARKET SIZE, BY VIRUSES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL MICROBIAL TESTING MARKET SIZE, BY CHEMICAL & MATERIAL MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL MICROBIAL TESTING MARKET SIZE, BY CLINICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL MICROBIAL TESTING MARKET SIZE, BY BLOODSTREAM INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL MICROBIAL TESTING MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL MICROBIAL TESTING MARKET SIZE, BY PERIODONTAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL MICROBIAL TESTING MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL MICROBIAL TESTING MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL MICROBIAL TESTING MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL MICROBIAL TESTING MARKET SIZE, BY ENVIRONMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL MICROBIAL TESTING MARKET SIZE, BY SOIL CONTAMINATION ASSESSMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL MICROBIAL TESTING MARKET SIZE, BY WATER QUALITY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL MICROBIAL TESTING MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL MICROBIAL TESTING MARKET SIZE, BY FOOD TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL MICROBIAL TESTING MARKET SIZE, BY BEVERAGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL MICROBIAL TESTING MARKET SIZE, BY DAIRY PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL MICROBIAL TESTING MARKET SIZE, BY FRUITS & VEGETABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL MICROBIAL TESTING MARKET SIZE, BY POULTRY & MEAT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL MICROBIAL TESTING MARKET SIZE, BY SEAFOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL MICROBIAL TESTING MARKET SIZE, BY FOOD TESTING, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL MICROBIAL TESTING MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS MICROBIAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS MICROBIAL TESTING MARKET SIZE, BY IMMUNOLOGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS MICROBIAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS MICROBIAL TESTING MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS MICROBIAL TESTING MARKET SIZE, BY FOOD TESTING, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS MICROBIAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA MICROBIAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA MICROBIAL TESTING MARKET SIZE, BY IMMUNOLOGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA MICROBIAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA MICROBIAL TESTING MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA MICROBIAL TESTING MARKET SIZE, BY FOOD TESTING, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL MICROBIAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL MICROBIAL TESTING MARKET SIZE, BY IMMUNOLOGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL MICROBIAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL MICROBIAL TESTING MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 72. BRAZIL MICROBIAL TESTING MARKET SIZE, BY FOOD TESTING, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA MICROBIAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA MICROBIAL TESTING MARKET SIZE, BY IMMUNOLOGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA MICROBIAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 79. CANADA MICROBIAL TESTING MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA MICROBIAL TESTING MARKET SIZE, BY FOOD TESTING, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO MICROBIAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO MICROBIAL TESTING MARKET SIZE, BY IMMUNOLOGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO MICROBIAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO MICROBIAL TESTING MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 88. MEXICO MICROBIAL TESTING MARKET SIZE, BY FOOD TESTING, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES MICROBIAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES MICROBIAL TESTING MARKET SIZE, BY IMMUNOLOGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES MICROBIAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES MICROBIAL TESTING MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES MICROBIAL TESTING MARKET SIZE, BY FOOD TESTING, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES MICROBIAL TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC MICROBIAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC MICROBIAL TESTING MARKET SIZE, BY IMMUNOLOGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC MICROBIAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC MICROBIAL TESTING MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC MICROBIAL TESTING MARKET SIZE, BY FOOD TESTING, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC MICROBIAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. AUSTRALIA MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. AUSTRALIA MICROBIAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA MICROBIAL TESTING MARKET SIZE, BY IMMUNOLOGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 110. AUSTRALIA MICROBIAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. AUSTRALIA MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA MICROBIAL TESTING MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 114. AUSTRALIA MICROBIAL TESTING MARKET SIZE, BY FOOD TESTING, 2018-2030 (USD MILLION)
  • TABLE 115. CHINA MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. CHINA MICROBIAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. CHINA MICROBIAL TESTING MARKET SIZE, BY IMMUNOLOGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 118. CHINA MICROBIAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. CHINA MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. CHINA MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 121. CHINA MICROBIAL TESTING MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 122. CHINA MICROBIAL TESTING MARKET SIZE, BY FOOD TESTING, 2018-2030 (USD MILLION)
  • TABLE 123. INDIA MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. INDIA MICROBIAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. INDIA MICROBIAL TESTING MARKET SIZE, BY IMMUNOLOGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 126. INDIA MICROBIAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. INDIA MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. INDIA MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 129. INDIA MICROBIAL TESTING MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 130. INDIA MICROBIAL TESTING MARKET SIZE, BY FOOD TESTING, 2018-2030 (USD MILLION)
  • TABLE 131. INDONESIA MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. INDONESIA MICROBIAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. INDONESIA MICROBIAL TESTING MARKET SIZE, BY IMMUNOLOGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 134. INDONESIA MICROBIAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. INDONESIA MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. INDONESIA MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 137. INDONESIA MICROBIAL TESTING MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 138. INDONESIA MICROBIAL TESTING MARKET SIZE, BY FOOD TESTING, 2018-2030 (USD MILLION)
  • TABLE 139. JAPAN MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. JAPAN MICROBIAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. JAPAN MICROBIAL TESTING MARKET SIZE, BY IMMUNOLOGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 142. JAPAN MICROBIAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. JAPAN MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. JAPAN MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 145. JAPAN MICROBIAL TESTING MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 146. JAPAN MICROBIAL TESTING MARKET SIZE, BY FOOD TESTING, 2018-2030 (USD MILLION)
  • TABLE 147. MALAYSIA MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. MALAYSIA MICROBIAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. MALAYSIA MICROBIAL TESTING MARKET SIZE, BY IMMUNOLOGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 150. MALAYSIA MICROBIAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. MALAYSIA MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. MALAYSIA MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 153. MALAYSIA MICROBIAL TESTING MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 154. MALAYSIA MICROBIAL TESTING MARKET SIZE, BY FOOD TESTING, 2018-2030 (USD MILLION)
  • TABLE 155. PHILIPPINES MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. PHILIPPINES MICROBIAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. PHILIPPINES MICROBIAL TESTING MARKET SIZE, BY IMMUNOLOGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 158. PHILIPPINES MICROBIAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. PHILIPPINES MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. PHILIPPINES MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 161. PHILIPPINES MICROBIAL TESTING MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 162. PHILIPPINES MICROBIAL TESTING MARKET SIZE, BY FOOD TESTING, 2018-2030 (USD MILLION)
  • TABLE 163. SINGAPORE MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. SINGAPORE MICROBIAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 165. SINGAPORE MICROBIAL TESTING MARKET SIZE, BY IMMUNOLOGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 166. SINGAPORE MICROBIAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SINGAPORE MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SINGAPORE MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 169. SINGAPORE MICROBIAL TESTING MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 170. SINGAPORE MICROBIAL TESTING MARKET SIZE, BY FOOD TESTING, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH KOREA MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH KOREA MICROBIAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. SOUTH KOREA MICROBIAL TESTING MARKET SIZE, BY IMMUNOLOGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 174. SOUTH KOREA MICROBIAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SOUTH KOREA MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SOUTH KOREA MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 177. SOUTH KOREA MICROBIAL TESTING MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 178. SOUTH KOREA MICROBIAL TESTING MARKET SIZE, BY FOOD TESTING, 2018-2030 (USD MILLION)
  • TABLE 179. TAIWAN MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. TAIWAN MICROBIAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 181. TAIWAN MICROBIAL TESTING MARKET SIZE, BY IMMUNOLOGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 182. TAIWAN MICROBIAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. TAIWAN MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. TAIWAN MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 185. TAIWAN MICROBIAL TESTING MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 186. TAIWAN MICROBIAL TESTING MARKET SIZE, BY FOOD TESTING, 2018-2030 (USD MILLION)
  • TABLE 187. THAILAND MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. THAILAND MICROBIAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 189. THAILAND MICROBIAL TESTING MARKET SIZE, BY IMMUNOLOGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 190. THAILAND MICROBIAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. THAILAND MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. THAILAND MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 193. THAILAND MICROBIAL TESTING MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 194. THAILAND MICROBIAL TESTING MARKET SIZE, BY FOOD TESTING, 2018-2030 (USD MILLION)
  • TABLE 195. VIETNAM MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 196. VIETNAM MICROBIAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. VIETNAM MICROBIAL TESTING MARKET SIZE, BY IMMUNOLOGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 198. VIETNAM MICROBIAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. VIETNAM MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. VIETNAM MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 201. VIETNAM MICROBIAL TESTING MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 202. VIETNAM MICROBIAL TESTING MARKET SIZE, BY FOOD TESTING, 2018-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA MICROBIAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA MICROBIAL TESTING MARKET SIZE, BY IMMUNOLOGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA MICROBIAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA MICROBIAL TESTING MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA MICROBIAL TESTING MARKET SIZE, BY FOOD TESTING, 2018-2030 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA MICROBIAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 212. DENMARK MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 213. DENMARK MICROBIAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 214. DENMARK MICROBIAL TESTING MARKET SIZE, BY IMMUNOLOGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 215. DENMARK MICROBIAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. DENMARK MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. DENMARK MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 218. DENMARK MICROBIAL TESTING MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 219. DENMARK MICROBIAL TESTING MARKET SIZE, BY FOOD TESTING, 2018-2030 (USD MILLION)
  • TABLE 220. EGYPT MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 221. EGYPT MICROBIAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 222. EGYPT MICROBIAL TESTING MARKET SIZE, BY IMMUNOLOGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 223. EGYPT MICROBIAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. EGYPT MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. EGYPT MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 226. EGYPT MICROBIAL TESTING MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 227. EGYPT MICROBIAL TESTING MARKET SIZE, BY FOOD TESTING, 2018-2030 (USD MILLION)
  • TABLE 228. FINLAND MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. FINLAND MICROBIAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 230. FINLAND MICROBIAL TESTING MARKET SIZE, BY IMMUNOLOGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 231. FINLAND MICROBIAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. FINLAND MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. FINLAND MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 234. FINLAND MICROBIAL TESTING MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 235. FINLAND MICROBIAL TESTING MARKET SIZE, BY FOOD TESTING, 2018-2030 (USD MILLION)
  • TABLE 236. FRANCE MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 237. FRANCE MICROBIAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 238. FRANCE MICROBIAL TESTING MARKET SIZE, BY IMMUNOLOGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 239. FRANCE MICROBIAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. FRANCE MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 241. FRANCE MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 242. FRANCE MICROBIAL TESTING MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 243. FRANCE MICROBIAL TESTING MARKET SIZE, BY FOOD TESTING, 2018-2030 (USD MILLION)
  • TABLE 244. GERMANY MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 245. GERMANY MICROBIAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 246. GERMANY MICROBIAL TESTING MARKET SIZE, BY IMMUNOLOGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 247. GERMANY MICROBIAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
  • TABLE 248. GERMANY MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 249. GERMANY MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 250. GERMANY MICROBIAL TESTING MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 251. GERMANY MICROBIAL TESTING MARKET SIZE, BY FOOD TESTING, 2018-2030 (USD MILLION)
  • TABLE 252. ISRAEL MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 253. ISRAEL MICROBIAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 254. ISRAEL MICROBIAL TESTING MARKET SIZE, BY IMMUNOLOGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 255. ISRAEL MICROBIAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. ISRAEL MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 257. ISRAEL MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 258. ISRAEL MICROBIAL TESTING MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 259. ISRAEL MICROBIAL TESTING MARKET SIZE, BY FOOD TESTING, 2018-2030 (USD MILLION)
  • TABLE 260. ITALY MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 261. ITALY MICROBIAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 262. ITALY MICROBIAL TESTING MARKET SIZE, BY IMMUNOLOGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 263. ITALY MICROBIAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
  • TABLE 264. ITALY MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 265. ITALY MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 266. ITALY MICROBIAL TESTING MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 267. ITALY MICROBIAL TESTING MARKET SIZE, BY FOOD TESTING, 2018-2030 (USD MILLION)
  • TABLE 268. NETHERLANDS MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 269. NETHERLANDS MICROBIAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 270. NETHERLANDS MICROBIAL TESTING MARKET SIZE, BY IMMUNOLOGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 271. NETHERLANDS MICROBIAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
  • TABLE 272. NETHERLANDS MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 273. NETHERLANDS MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 274. NETHERLANDS MICROBIAL TESTING MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 275. NETHERLANDS MICROBIAL TESTING MARKET SIZE, BY FOOD TESTING, 2018-2030 (USD MILLION)
  • TABLE 276. NIGERIA MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 277. NIGERIA MICROBIAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 278. NIGERIA MICROBIAL TESTING MARKET SIZE, BY IMMUNOLOGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 279. NIGERIA MICROBIAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
  • TABLE 280. NIGERIA MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 281. NIGERIA MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 282. NIGERIA MICROBIAL TESTING MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 283. NIGERIA MICROBIAL TESTING MARKET SIZE, BY FOOD TESTING, 2018-2030 (USD MILLION)
  • TABLE 284. NORWAY MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 285. NORWAY MICROBIAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 286. NORWAY MICROBIAL TESTING MARKET SIZE, BY IMMUNOLOGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 287. NORWAY MICROBIAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
  • TABLE 288. NORWAY MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 289. NORWAY MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 290. NORWAY MICROBIAL TESTING MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 291. NORWAY MICROBIAL TESTING MARKET SIZE, BY FOOD TESTING, 2018-2030 (USD MILLION)
  • TABLE 292. POLAND MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 293. POLAND MICROBIAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 294. POLAND MICROBIAL TESTING MARKET SIZE, BY IMMUNOLOGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 295. POLAND MICROBIAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
  • TABLE 296. POLAND MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 297. POLAND MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 298. POLAND MICROBIAL TESTING MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 299. POLAND MICROBIAL TESTING MARKET SIZE, BY FOOD TESTING, 2018-2030 (USD MILLION)
  • TABLE 300. QATAR MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 301. QATAR MICROBIAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 302. QATAR MICROBIAL TESTING MARKET SIZE, BY IMMUNOLOGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 303. QATAR MICROBIAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
  • TABLE 304. QATAR MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 305. QATAR MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 306. QATAR MICROBIAL TESTING MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 307. QATAR MICROBIAL TESTING MARKET SIZE, BY FOOD TESTING, 2018-2030 (USD MILLION)
  • TABLE 308. RUSSIA MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 309. RUSSIA MICROBIAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 310. RUSSIA MICROBIAL TESTING MARKET SIZE, BY IMMUNOLOGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 311. RUSSIA MICROBIAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
  • TABLE 312. RUSSIA MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 313. RUSSIA MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 314. RUSSIA MICROBIAL TESTING MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 315. RUSSIA MICROBIAL TESTING MARKET SIZE, BY FOOD TESTING, 2018-2030 (USD MILLION)
  • TABLE 316. SAUDI ARABIA MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 317. SAUDI ARABIA MICROBIAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 318. SAUDI ARABIA MICROBIAL TESTING MARKET SIZE, BY IMMUNOLOGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 319. SAUDI ARABIA MICROBIAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
  • TABLE 320. SAUDI ARABIA MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 321. SAUDI ARABIA MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 322. SAUDI ARABIA MICROBIAL TESTING MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 323. SAUDI ARABIA MICROBIAL TESTING MARKET SIZE, BY FOOD TESTING, 2018-2030 (USD MILLION)
  • TABLE 324. SOUTH AFRICA MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 325. SOUTH AFRICA MICROBIAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 326. SOUTH AFRICA MICROBIAL TESTING MARKET SIZE, BY IMMUNOLOGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 327. SOUTH AFRICA MICROBIAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
  • TABLE 328. SOUTH AFRICA MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 329. SOUTH AFRICA MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 330. SOUTH AFRICA MICROBIAL TESTING MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 331. SOUTH AFRICA MICROBIAL TESTING MARKET SIZE, BY FOOD TESTING, 2018-2030 (USD MILLION)
  • TABLE 332. SPAIN MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 333. SPAIN MICROBIAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 334. SPAIN MICROBIAL TESTING MARKET SIZE, BY IMMUNOLOGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 335. SPAIN MICROBIAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
  • TABLE 336. SPAIN MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 337. SPAIN MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 338. SPAIN MICROBIAL TESTING MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 339. SPAIN MICROBIAL TESTING MARKET SIZE, BY FOOD TESTING, 2018-2030 (USD MILLION)
  • TABLE 340. SWEDEN MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 341. SWEDEN MICROBIAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 342. SWEDEN MICROBIAL TESTING MARKET SIZE, BY IMMUNOLOGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 343. SWEDEN MICROBIAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
  • TABLE 344. SWEDEN MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 345. SWEDEN MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 346. SWEDEN MICROBIAL TESTING MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 347. SWEDEN MICROBIAL TESTING MARKET SIZE, BY FOOD TESTING, 2018-2030 (USD MILLION)
  • TABLE 348. SWITZERLAND MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 349. SWITZERLAND MICROBIAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 350. SWITZERLAND MICROBIAL TESTING MARKET SIZE, BY IMMUNOLOGICAL TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 351. SWITZERLAND MICROBIAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2030 (USD MILLION)
  • TABLE 352. SWITZERLAND MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 353. SWITZERLAND MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 354. SWITZERLAND MICROBIAL TESTING MARKET SIZE, BY ENVIRON